Amoeba SA Elevator Pitch | Biocontrol, Cosmetics & Commercial Growth

Amoeba SA Elevator Pitch: Key TakeawaysAmoéba SA Elevator Pitch PresentationIn this Elevator Pitch on seat11a, Jean-François Doucet, CEO of Amoéba SA, presents the company’s strategy, technology platform and commercial development plans across agriculture and cosmetics.A Green Technology Company Built on Proprietary Amoeba CultivationAmoéba is a French green technology company specializing in natural bio-solutions derived from proprietary amoeba cultivation technology. The company has spent more than a decade developing a unique industrial platform and has built a portfolio of intellectual property, industrial expertise and commercial partnerships designed to support future growth.Biological Crop Protection and Sustainable AgricultureThe company’s agricultural activities focus on biological crop protection products designed to offer natural alternatives to conventional chemical solutions. Regulatory milestones have already been achieved, including active substance approval in Europe and product authorization in the United States. These achievements provide the foundation for commercial deployment through strategic partnerships with major industry participants.Strategic Partnerships with Koppert and SyngentaAmoéba has signed an exclusive distribution agreement with Koppert for selected crop applications and has established a memorandum of understanding with Syngenta focused on future cereal opportunities. These partnerships provide access to large agricultural markets while leveraging established commercial infrastructures.Natural Cosmetic Ingredients and Well-Ageing SolutionsThe company is also developing a natural cosmetic ingredient targeting skin protection, repair and well-ageing applications. Through partnerships in China and international commercialization efforts, management sees cosmetics as an additional long-term growth driver supported by attractive market dynamics and higher-margin opportunities.Transition from Development to Commercial ExecutionThroughout the presentation, management emphasizes that Amoéba is transitioning from a development-stage story toward commercial execution. With technology validation, regulatory approvals, industrial partners and commercial agreements already in place, the company believes it is entering a new phase focused on market adoption and growth. ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&CThis publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.